Outcome and safety of self-expandable metallic stents for malignant colon obstruction: A Korean multicenter randomized prospective study

Surgical Endoscopy

Volumn 26, Issue 11, 2012, Pages 3106-3113

  Cheung, Dae Young ^a   Kim, Jin Yong ^b   Hong, Sung Pil ^c   Jung, Min Kyu ^d   Ye, Byong Duk ^e   Kim, Sang Gyun ^f   Kim, Jin Hong ^g   Lee, Kang Moon ^a   Kim, Kyung Ho ^h   Baik, Gwang Ho ^h   Kim, Ho Gak ⁱ   Eun, Chang Soo ^j   Kim, Tae Il ^c   Kim, Sang Woo ^a   Kim, Chang Duck ^k   Yang, Chang Heon ^l  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Kyungpook National University School of Medicine   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f Seoul National University College of Medicine   (South Korea)

^g Ajou University School of Medicine   (South Korea)

^h Hallym University College of Medicine   (South Korea)

ⁱ Catholic University of Daegu   (South Korea)

^j Hanyang University College of Medicine   (South Korea)

^k Korea University College of Medicine   (South Korea)

^l Dongguk University College of Medicine   (South Korea)

more..

Author keywords

Colon cancer; Obstruction; Self expandable metal stent

Indexed keywords

ADULT; ARTICLE; CANCER PALLIATIVE THERAPY; CLINICAL EFFECTIVENESS; COLON CANCER; COLON OBSTRUCTION; COLON PERFORATION; CONTROLLED STUDY; FEMALE; FOREIGN BODY; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT COLON OBSTRUCTION; METAL STENT; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SELF EXPANDING STENT; SOUTH KOREA; TREATMENT DURATION;

EID: 84871615336     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-012-2300-x     Document Type: Article

References (21)

1. Jemal A, Siegel R, Xu J et al (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277-300
2. Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917
3. Dutton JW, Hreno A, Hampson LG (1976) Mortality and prognosis of obstructing carcinoma of the large bowel. Am J Surg 131:36-41
4. Barillari P, Aurello P, De Angelis R et al (1992) Management and survival of patients affected with obstructive colorectal cancer. Int Surg 77:251-255
5. Carraro PG, Segala M, Cesana BM et al (2001) Obstructing colonic cancer: failure and survival patterns over a ten-year follow-up after one-stage curative surgery. Dis Colon Rectum 44: 243-250 (Pubitemid 32173774)
6. Cassidy J, Clarke S, Daz-Rubio E et al (2008) Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. J Clin Oncol 26:2006-2012
7. Kim JS, Hur H, Min BS et al (2009) Oncologic outcomes of selfexpanding metallic stent insertion as a bridge to surgery in the management of left-sided colon cancer obstruction: comparison with nonobstructing elective surgery. World J Surg 33:1281-doi:10.3748/wjg.v17.i28
8. Saltz LB, Clarke S, Daz-Rubio E et al (2008) Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 26:2013-2019
9. Andre T, Louvet C, Maindrault-Goebel F et al (1999) CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR. Eur J Cancer 35:1343-1347 (Pubitemid 29397434)
10. Kabbinavar F, Hambleton J, Mass RD et al (2005) Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol 23:3706-3712
11. Van Cutsem E, Twelves C, Cassidy J et al (2001) Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19:4097-4106 (Pubitemid 33049527)
12. Tejero E, Mainar A, Fernndez L et al (1994) New procedure for the treatment of colorectal neoplastic obstructions. Dis Colon Rectum 37:1158-1159 (Pubitemid 24366558)
13. Keen RR, Orsay CP (1992) Rectosigmoid stent for obstructing colonic neoplasms. Dis Colon Rectum 35:912-913
14. Vemulapalli R, Lara LF, Sreenarasimhaiah J et al (2010) A comparison of palliative stenting or emergent surgery for obstructing incurable colon cancer. Dig Dis Sci 55:1732-1737
15. Tilney HS, Lovegrove RE, Purkayastha S et al (2007) Comparison of colonic stenting and open surgery for malignant large bowel obstruction. Surg Endosc 21:225-233 (Pubitemid 46122408)
16. Repici A, Fregonese D, Costamagna G et al (2007) Ultraflex precision colonic stent placement for palliation of malignant colonic obstruction: a prospective multicenter study. Gastrointest Endosc 66:920-927 (Pubitemid 47610766)
17. Bretagnol F, Panis Y, Rullier E et al (2010) Rectal cancer surgery with or without bowel preparation: the French GRECCAR III multicenter single-blinded randomized trial. Ann Surg 252: 863-868
18. van Hooft JE, Fockens P, Marinelli AW et al (2008) Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer. Endoscopy 40:184-191 (Pubitemid 351404660)
19. Martinez-Santos C, Lobato RF, Fradejas JM et al (2002) Selfexpandable stent before elective surgery vs emergency surgery for the treatment of malignant colorectal obstructions: comparison of primary anastomosis and morbidity rates. Dis Colon Rectum 45:401-406 (Pubitemid 34273624)
20. Watt AM, Faragher IG, Griffin TT et al (2007) Self-expanding metallic stents for relieving malignant colorectal obstruction: a systematic review. Ann Surg 246:24-30 (Pubitemid 47012202)
21. Park S, Cheon JH, Park JJ et al (2010) Comparison of efficacies between stents for malignant colorectal obstruction: a randomized, prospective study. Gastrointest Endosc 72:304-310